📢 Addressing Cardiologist Shortage in Nearly Half of American Counties 📢 A recent study published in the Journal of the American College of Cardiology reveals that nearly half of American counties lack cardiologists. These areas, primarily rural and socioeconomically disadvantaged, face higher cardiovascular risk and mortality rates. AccurKardia’s ECG-driven AI technology can bridge this gap by enhancing access to quality cardiac care, ensuring timely and accurate ECG interpretations, and improving patient outcomes in underserved areas. Read more about the study: https://lnkd.in/eQvTBRyV #HealthcareAccess #Cardiology #AIinHealthcare #BetterOutcomesatHeart #HealthEquity
About us
AccurKardia is an ECG-led diagnostics software company. We are unlocking the value of the ECG signal towards broad diagnostics coverage and disease management in cardiology and beyond. This holds the key to improving clinical outcomes and saving lives globally. AccurKardia's first product, AccurECG is an FDA cleared (Class II SaMD), cloud-based, and device agnostic software for fully automated ECG interpretation and detection for up to 13 arrhythmias. It is intended to assist cardiac monitoring companies in the analysis of ECGs recorded from holters, event recorders and cardiac telemetry devices. Accepted into MedTech Innovator 2024 Cohort and the Heart and Brain Health Accelerator track in collaboration with the American Heart Association’s Center for Health Technology and Innovation.
- Website
-
http://www.accurkardia.com
External link for AccurKardia
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2019
- Specialties
- artificial intelligence, AI, cardiac healthcare, ecg analysis, healthtech, medtech, IoT, digitalhealth, medical devices, remote patient monitoring, and diagnostics
Locations
-
Primary
101 Avenue of the Americas
New York, NY 10013, US
Employees at AccurKardia
Updates
-
India is often associated with innovation in SaaS, IT Services, and BPO, however the India Deep Tech, MedTech, and AI story is still being written and will be as revolutionary, if not more, than what has come before. AccurKardia is privileged to be a part of that story, and it was great to be able to present our vision of AI in ECG-led screening and diagnostics at the India Global Forum's flagship event in London a few weeks ago. Look forward to future events! cc: Juan C Jimenez, Mohamed Sadeq Ali, Moin Hussaini, Dr. Nav Razvi, Naveen Srinivas, Tony M Kuttiachen
Here’s a quick download on Part 2 of the pitches made during the ‘Pitchers & Punters’ session on Day 5 of #IGFLondon. It was exciting to get immersed into a world of innovative ideas, fuelled by new-age technology and the drive to offer solutions to problems impacting people’s lives. These are ideas which have the potential to turn into something really big. Which one do you think made the cut and impressed our judges, The Punters? We announce the winner soon! Stay tuned… #JoinTheConversation: www.indiaglobalforum.com #TechnologyAndInnovation #GlobalSummit #Startups #BusinessIdeas #GlobalEvent #Funding #BusinessLeadership vCare Denmark stratpilot.ai Kesowa PhenUtest Diagnostics AccurKardia
-
We're thrilled to announce that our Co-Founder & CEO, Juan C Jimenez, will be participating in the "From Lab to Market: Founder Stories in Healthcare Innovation" panel on July 15 at GEC+ Puerto Rico! 🌟 Join founders, investors, policymakers, and more from across Latin America, the Caribbean, and the US Hispanic and Latino communities to develop an ambitious roadmap for a vibrant economy by 2035. Don't miss this opportunity to engage with leading voices in healthcare innovation. Learn more: www.gecplus.co/puertorico #GECPlusPR #Vision2035 #betteroutcomes #innovation #AIinhealthcare
-
-
📘 Exciting Read! 📘 Published in the Journal of the American College of Cardiology: "Transforming Cardiovascular Care With Artificial Intelligence." This paper highlights AI's role in enhancing diagnostic accuracy and patient outcomes, emphasizing ECG as a biomarker. This aligns with AccurKardia's work leveraging AI in ECG diagnostics, enabling precise, real-time interpretations, expanding ECG use beyond arrhythmia detection, and extending cardiac care accessibility. Read the full paper here: https://lnkd.in/eHHgMj_N #betteroutcomesatheart #AIinHealthcare #ECG #Biomarkers #HealthcareInnovation #JACC
Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review
jacc.org
-
AccurKardia reposted this
🇺🇸 AccurKardia wishes you a Happy Independence Day! 🇺🇸 As we celebrate the 4th of July, we honor the spirit of freedom and innovation that drives our mission to improve patient outcomes and save lives. Wishing everyone a joyful holiday. Happy Independence Day! 🎆🎇 #IndependenceDay #FourthOfJuly #Celebration #HealthcareInnovation #betteroutcomes
-
-
🇺🇸 AccurKardia wishes you a Happy Independence Day! 🇺🇸 As we celebrate the 4th of July, we honor the spirit of freedom and innovation that drives our mission to improve patient outcomes and save lives. Wishing everyone a joyful holiday. Happy Independence Day! 🎆🎇 #IndependenceDay #FourthOfJuly #Celebration #HealthcareInnovation #betteroutcomes
-
-
Our Co-founder and COO, Mohamed Sadeq Ali had the honor of representing AccurKardia at the 6th annual India Global Forum in London and Windsor this past week. This years forum focused on Imagining a Limitless Future in 2035, and in the keynote on the topic, the amazing Umang Bedi's prediction #1 was "AI Doctors Now a Standard"! Every sector of our economy will be changed forever by AI, but perhaps none more so than healthcare. In keeping with this topic Sadeq was was invited to a roundtable on "Healthcare 2030 – Innovations and Opportunities", and given the opportunity to present AccurKardia at the grand finale of the week, "Pitchers and Punters", in front of some amazing punters including the legendary Mr. Sanjay Nayar, the current head of Sorin Investments and previously the India head of KKR. It was also amazing to be at the Awards Dinner amongst luminaries of Indian film and sport including Olympic Gold Medalist Abhinav Bindra, National Award and 8-time Cannes featured, Nawazuddin Siddiqui, and Dr. Deepa Malik, India's first Female Paralympic Medallist. A huge thank you to Utkarsh Amitabh and Network Capital, as well as Vaiibhav Kapoor and Gowri Natarajan for making this happen, and a huge shoutout to Manoj Ladwa on bringing together a phenomenal group of people year after year! cc: Juan C Jimenez, Dr. Nav Razvi, Moin Hussaini
-
-
-
-
-
+1
-
-
AccurKardia reposted this
Our June newsletter just dropped & highlights all of the amazing work our members and the digital health community have accomplished this past month. Featured companies include: Nym | Tomorrow Health | HTD Health | Canopy | IQVIA United States Digital Enablement Center of Excellence | Deloitte | AccurKardia | BDO | Vivante Health | Yuvo Health | McDermott Will & Emery | TailorMed | Oshi Health | COPE Health Solutions | GoMo Health Read more from the community here: https://lnkd.in/g5Un9bww
-
-
📢 Check out this TED Talk by Eric Topol, MD from Scripps Research: "Can AI Catch What Doctors Miss?" Dr. Topol states, “Imagine getting an electrocardiogram to tell you about all these other things, not really so much about the heart.” At AccurKardia, we are leveraging ECGs to unlock their value as biomarkers for use in cardiology and beyond, enhancing patient outcomes and saving lives. Watch the full video here: https://lnkd.in/dr6Y_jFa #AIinHealthcare #betteroutcomesatheart #CardiacCare #MedTech #ECGAnalysis
Can AI Catch What Doctors Miss? | Eric Topol | TED
https://www.youtube.com/
-
Thanks LSI for sharing. #betteroutcomesatheart #innovation #healthtech
AccurKardia is delivering clinical-grade ECG interpretation software, to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. Their flagship product, the AccurECG™ Analysis System is an FDA cleared, cloud-based, device-agnostic and fully automated electrocardiogram (ECG) interpretation software platform. The software provides an array of benefits, such as beat-by-beat analysis, ventricular/supraventricular ectopic beat detection, heart rate measurement and automated interpretation of 13 different heart rhythms including sinus tachycardia, sinus bradycardia, atrial fibrillation and atrial flutter, among others. The fully automated output of AccurECG™ improves clinicians’ review efficiencies and enables prompt treatment of patients, with results delivered in minutes. It is indicated for adults aged 22 and older. Catch the latest from AccurKardia. Tune into Juan C Jimenez and Moin Hussaini’s Studio Interview and presentation from LSI USA ‘24 to learn more about AccurKardia’s recent progress. Available now on our website and YouTube channel.